News

The shift was a marked departure from previous FDA guidance, which recommended an annual COVID vaccine for everyone 6 months ...
The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...
On May 20, 2025, the Food and Drug Administration announced a new stance on who should receive the COVID-19 vaccine.
The US Food and Drug Administration (FDA) announced today that it will only recommend COVID-19 vaccines for adults 65 and ...
FDA leaders say the agency will require more clinical trials to show the benefits of annual COVID shots for healthy adults.
The FDA will now require clinical trials to approve boosters for healthy Americans under 65, making it unlikely the shots ...
New guidelines for COVID vaccine. Prior to the new guidelines, it was recommended that everyone who is 6 months and older get ...
In this week’s edition of InnovationRx, we look at the FDA's new rules on Covid-19 vaccines, Novartis’s acquisition strategy, ...
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
For groups younger than 65 or without specific chronic conditions, postmarketing trials will be needed to open access.
The FDA will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to ...
The US Food and Drug Administration (FDA) announces new regulatory guidelines for future COVID-19 vaccines and booster shots.